KAI Pharmaceuticals
Palo Alto, CA
CEO: Stephen James
http://www.kaipharmaceuticals.com
KAI Pharmaceuticals is a drug discovery and development company with clinical-stage programs in cardiovascular disease and pain. KAI’s expertise is in the selective modulation of intracellular protein:protein interactions via the delivery of peptide drugs into the cell. The company has applied its core technology to discover inhibitors and activators for members of the protein kinase C (PKC) family of isozymes.
